Table 1.
Baseline features of treatment groups (n = 98)
| Feature | HAPIFED (n = 50) Mean (SD) |
CBT-E (n = 48) Mean (SD) |
p a |
|---|---|---|---|
| Weight, kg | 88.96 (11.93) | 89.59 (13.34) | 0.805a |
| Body mass index, kg/m2 | 33.62 (3.19) | 33.74 (3.47) | 0.854a |
| Waist circumference, cm | 105.18 (10.86) | 104.9 (10.74) | 0.901a |
| Hip circumference, cm | 118.83 (8.29) | 118.84 (8.57) | 0.991a |
| Serum glucose, mg/dL | 93.51 (8.08) | 94.49 (10.97) | 0.627a |
| Serum insulin, ulU/mL | 13.57 (6.55) | 12.64 (9.34) | 0.583a |
| Serum triglycerides, mg/dL | 147.66 (159.54) | 123.98 (77.21) | 0.371a |
| Serum HDL cholesterol, mg/dL | 54.55 (11.35) | 53.84 (12.04) | 0.772a |
| Serum LDL cholesterol, mg/dL | 117.50 (31.93) | 113.84 (22.46) | 0.529a |
| SF12 Physical health component summary | 47.22 (10.49) | 49.97 (9.08) | 0.167a |
| SF12 Mental health component summary | 34.31 (10.03) | 36.92 (11.73) | 0.238a |
| DASS – depression subscale | 16.38 (10.86) | 16.25 (11.70) | 0.955a |
| DASS – anxiety subscale | 10.36 (7.43) | 11.21 (9.41) | 0.621a |
| DASS – stress subscale | 20.12 (8.60) | 22.17 (10.11) | 0.283a |
| Binge Eating Scale | 29.84 (8.11) | 28.67 (7.33) | 0.455a |
| Eating Disorder Examination Questionnaire | 3.64 (1.10) | 3.46 (0.95) | 0.395a |
| N (%) | N (%) | ||
| DSM-5 diagnoses | 0.597b | ||
| Binge eating disorder | 30 (60.00) | 36 (75.00) | |
| Bulimia nervosa | 8 (16.00) | 5 (10.42) | |
| OSFED/UFED | 12 (24.00) | 7 (14.58) |
HDL High-Density Lipoprotein, LDL Low-Density Lipoprotein, SF-12 12-item Short Form Health Survey, DASS Depression, Anxiety and Stress Scale, OSFED other specified feeding or eating disorder, UFED unspecified feeding or eating disorder. Note: All serum measurements were made in the fasted state
a T test; b Fisher’s test